Inventor · Duluth, GA, US

Mark Newman

12Patents
5h-index
22Co-inventors
66Inventor score

Filing activity: Aug 9, 1995 → Dec 22, 2015

Most-cited inventions

PatentTitleAreaCited byStatus
US7462354B2 Method and system for optimizing minigenes and peptides encoded thereby Emerging Cross-Sectional Technologies 27 Expired
US6416947B1 Vaccine adjuvant and vaccine method Human Necessities 26 Expired
US7888472B2 Optimized multi-epitope constructs and uses thereof Chemistry; Metallurgy 9 Active
US6086899A Vaccine adjuvant and vaccine Human Necessities 7 Expired
US6933286B2 Therapeutic delivery compositions and methods of use thereof Chemistry; Metallurgy 6 Expired
US7507803B2 Optimized multi-epitope constructs and uses thereof Chemistry; Metallurgy 3 Expired
US6149922A Vaccine adjuvant and vaccine Human Necessities 3 Expired
US6844001B2 Adjuvants and copolymer compositions Human Necessities 3 Expired
US7045576B2 Adjuvants and copolymer compositions Human Necessities 3 Expired
US9249187B2 Pan-DR binding polypeptides and uses thereof Chemistry; Metallurgy 2 Active
US9789181B2 PAN-DR binding polypeptides and uses thereof Chemistry; Metallurgy 0 Active
US9511134B2 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.